jcm-logo

Journal Browser

Journal Browser

Robotic Surgery in Urology: Current Advances and Future Perspectives

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".

Deadline for manuscript submissions: 22 December 2026 | Viewed by 558

Editor


E-Mail Website
Guest Editor
Department of Urology, San Camillo De Lellis Hospital, 02100 Rieti, Italy
Interests: laparoscopic urology; endourology; urologic oncology; urolithiasis; robotics & minimally invasive urology; urologic surgical procedures; kidney cancer; bladder cancer; prostate cancer; artificial intelligence
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are pleased to inform you that we are organizing a new Special Issue entitled “Robotic Surgery in Urology: Current Advances and Future Perspectives” for the Journal of Clinical Medicine.

Robotic surgery has become the surgical approach of choice in modern urology, moving from limited indications to standard of care for major malignant and benign urological conditions, particularly in oncology and reconstructive procedures. Recent advances focus on the availability of multiple robotic platforms, single-port technology, augmented reality and sensory simulation, as well as the use of artificial intelligence, increasingly enabling precision surgery.

The purpose of this Special Issue is to summarize the latest innovations in robotic surgery in urology and the future perspectives that may be derived from current research.

Urologists and engineers are encouraged to submit their findings as original articles or reviews to this Special Issue.

Dr. Davide Campobasso
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • augmented reality
  • augmented sensations
  • artificial intelligence
  • single-port
  • reconstructive surgery
  • oncological surgery
  • image-guided surgery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1223 KB  
Article
Refining the Predictive Accuracy of Membranous Urethral Length for Post-Prostatectomy Incontinence: A Standardized Approach in the Korean Population
by Jong Kyou Kwon, Do Kyung Kim, Jin hyung Jeon, Sungun Bang, Kyo Chul Koo, Kwang Suk Lee, Eun-Suk Cho and Kang Su Cho
J. Clin. Med. 2026, 15(12), 4454; https://doi.org/10.3390/jcm15124454 - 9 Jun 2026
Viewed by 382
Abstract
Background/Objectives: Preoperative membranous urethral length (MUL) is a predictor of post-prostatectomy urinary incontinence. However, measurement inconsistencies have hindered the establishment of ethnically specific clinical thresholds. We identified precise and internally validated MUL cutoff values for persistent incontinence at 6 and 12 months in [...] Read more.
Background/Objectives: Preoperative membranous urethral length (MUL) is a predictor of post-prostatectomy urinary incontinence. However, measurement inconsistencies have hindered the establishment of ethnically specific clinical thresholds. We identified precise and internally validated MUL cutoff values for persistent incontinence at 6 and 12 months in a Korean cohort using a standardized measurement protocol. Methods: We retrospectively analyzed 151 patients who underwent robot-assisted radical prostatectomy (RARP) between 2022 and 2024. Preoperative MUL was measured using a 3-axis cross-reference system (CRS) on 3.0T mpMRI. Continence was defined as 0 or 1 safety pad per day. Independent predictors were identified via multivariable logistic regression, and the optimal cutoff values were determined using the Youden index with 1000-iteration bootstrap validation. Results: Preoperative MUL was significantly longer in continent than in incontinent patients at 6 (16.7 vs. 13.7 mm) and 12 months (16.7 vs. 11.3 mm; both p < 0.001). In the multivariable analysis, MUL was the only significant independent predictor for persistent incontinence (6 months: OR 0.798, p < 0.001; 12 months: OR 0.586, p < 0.001). The univariable AUROCs for predicting persistent incontinence were 0.707 (6 months) and 0.875 (12 months), whereas the multivariable AUROCs were 0.756 and 0.883, respectively. Optimal cutoff values from bootstrap were 14.00 mm (95% confidence interval [CI], 11.43–16.68) for 6-month and 12.60 mm (95% CI, 11.43–14.37) for 12-month persistent incontinence. Conclusions: Using a standardized CRS protocol, this study provides validated population-specific MUL thresholds for predicting persistent incontinence after RARP in Korean men, offering a pragmatic framework for preoperative risk stratification and evidence-based patient counseling. Full article
(This article belongs to the Special Issue Robotic Surgery in Urology: Current Advances and Future Perspectives)
Show Figures

Figure 1

Back to TopTop